Sign In
Buy ONCY
$0.94
+0.0237 (+2.58%)
At Close: Jun 23, 2026
Oncolytics Biotech® Presents Preclinical Data on Pelareorep-based Combination Therapies at the AACR Annual Meeting
07:00am, Monday, 12'th Apr 2021
SAN DIEGO and CALGARY, AB, April 12, 2021 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) recently announced preclinical data highlighting pelareorep's ability to synergize with
Oncolytics Biotech® to Participate in a Panel Discussion at the Canaccord Genuity Horizons in Oncology Virtual Conference
07:00am, Thursday, 08'th Apr 2021
SAN DIEGO and CALGARY, Alberta, April 8, 2021 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that Dr. Matt Coffey, the Company's President and Chief Executive Of
Our First Look At Oncolytics Biotech
12:29pm, Tuesday, 06'th Apr 2021
Today, we take a look at an 'off the radar' development concern named Oncolytics Biotech. The company's primary drug candidate is advancing in several trials in combination with various checkpoint inh
SAN DIEGO and CALGARY, AB, April 5, 2021 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that it will host a Key Opinion Leader (KOL) webinar discussing AWARE-1 da
Oncolytics Biotech (ONCY) Enters Overbought Territory
09:51am, Thursday, 25'th Mar 2021
Oncolytics Biotech (ONCY) has moved higher as of late, but there could definitely be trouble on the horizon for this company
Oncolytics Biotech® Announces Upcoming Presentations at the AACR Annual Meeting
04:32pm, Wednesday, 10'th Mar 2021
SAN DIEGO and CALGARY, AB, March 10, 2021 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that it will present updated clinical data from its AWARE-1 window-of-op
Oncolytics Biotech Inc. (ONCY) CEO Dr. Matt Coffey on Q4 2020 Results - Earnings Call Transcript
12:13pm, Friday, 05'th Mar 2021
Oncolytics Biotech Inc. (ONCY) CEO Dr. Matt Coffey on Q4 2020 Results - Earnings Call Transcript
Oncolytics Biotech® Establishes New At-The-Market Facility
07:32am, Friday, 05'th Mar 2021
SAN DIEGO, Calif. and CALGARY, AB, March 5, 2021 /PRNewswire/ ---- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic vir
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
07:30am, Friday, 05'th Mar 2021
- New clinical data highlight pelareorep's potential to boost the effectiveness of checkpoint inhibitors - Clinical demonstration of pelareorep reversing immunosuppressive tumor microenvironments - On
Why Bausch Health, Oncolytics Biotech, And More Are Moving Today
01:01pm, Wednesday, 17'th Feb 2021
iBio (NYSE: IBIO) shares are trading lower Wednesday after the company reported second-quarter earnings results. iBio's main area of business is plant-based protein expression technologies for vaccine
ONCY Stock Price Increases Over 60% Pre-Market: Why It Happened
08:54am, Wednesday, 17'th Feb 2021
The stock price of Oncolytics Biotech, Inc. (NASDAQ: ONCY) is trading at over 60% pre-market. This is why it happened.
Is Oncolytics Biotech, Inc. (ONCY) A Good Stock To Buy?
06:15pm, Thursday, 26'th Nov 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 817 13F filing
Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Operational Highlights
07:00am, Friday, 06'th Nov 2020
- Conference call and webcast to take place on Wednesday, November 11, 2020 at 5:00 pm ET SAN DIEGO and CALGARY, AB, Nov. 6, 2020 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) to
CytoDyn's COVID-19 Trial, And Other News: The Good, Bad And Ugly Of Biopharma
06:55am, Monday, 31'st Aug 2020
CytoDyn advances enrollment in Phase 3 COVID-19 trial. Oncolytics Biotech starts dosing in IRENE study.
Oncolytics Biotech® to Participate in Virtual Fireside Chat at the Canaccord Genuity 40th Annual Growth Conference
11:00am, Monday, 10'th Aug 2020
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that the Company will participate in a virtual fireside chat at the Canaccord Genuity 40th Annual Growth Conference. Presentation de
